Extranodal NK/T-cell Lymphoma, Nasal Type

A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type

A Registry for People With T-cell Lymphoma

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms

Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL

Doxorubicin, CC-(486) (5-azacitidine), Romidepsin, and Duvelisib (hARD) for T-cell Lymphoma

GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma

Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients

MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma

Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL

SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma

Maintenance Therapy With Anti-PD-1 Antibody for Patients With NK/T-cell Lymphoma

International Extranodal NK/T-cell Lymphoma Project

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma

Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma

Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma

Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma

Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma